Modified patient stem cells as prelude to autologous treatment of muscular dystrophy.
作者:
Davies(Kay E),Grounds(Miranda D)
状态:
发布时间2008-03-28
, 更新时间 2016-11-24
期刊:
Cell Stem Cell
摘要:
Duchenne muscular dystrophy is a devastating muscle wasting disease for which there is no effective treatment. In this issue of Cell Stem Cell, Benchaouir et al. (2007) demonstrate the delivery of genetically corrected CD133+ patient cells into mice, suggesting a new potential avenue for autologous cell therapy.